PB2022: EXPLORING ALTERNATIVE DOSING REGIMENS OF SINGLE-AGENT BELANTAMAB MAFODOTIN ON SAFETY AND EFFICACY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DREAMM-14

Bibliographic Details
Main Authors:	M. Hultcrantz, D. Kleinman, P. Ghataorhe, A. Mckeown, W. He, T. Ling, R. C. Jewell, J. Byrne, L. Eliason, E. Scott, J. Opalinska
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850920.41716.f0

Internet